# T21,18 and 13 Screening by Cell Free Fetal DNA in Low Risk Patients

> **NCT02424474** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 933 (actual)

## Conditions studied

- Trisomy 21, 18 and 13 Screening

## Interventions

- **DEVICE:** Genetic NIPT
- **BIOLOGICAL:** Regular serum screening

## Key facts

- **NCT ID:** NCT02424474
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-09
- **Final completion:** 2017-02-14
- **Target enrollment:** 933 (ACTUAL)
- **Last updated:** 2017-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02424474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02424474, "T21,18 and 13 Screening by Cell Free Fetal DNA in Low Risk Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02424474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*